Skip to content

Organon OGN Enterprise value

Enterprise value at other companies

Pfizer logo
PfizerPFE
$222.4B+9.2%
Amgen logo
AmgenAMGN
$246.43B+9.9%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$15.19B-20.2%
Biogen logo
BiogenBIIB
$30.08B+34.9%
AbbVie logo
AbbVieABBV
$460.96B+24.7%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$6.34B+33.4%

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%
P/E6.6×+2.1×
P/S0.6×-0.8×

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Calculated from Organon’s reported figures.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's enterprise value?
Organon (OGN) reported enterprise value of $9.01B in Q1 2026.
How has Organon's enterprise value changed year-over-year?
Organon's enterprise value decreased by 26.4% year-over-year, from $12.25B to $9.01B.
What is the long-term trend for Organon's enterprise value?
Over 4 years (2021 to 2025), Organon's enterprise value has grown at a -11.4% compound annual growth rate (CAGR), from $16.35B to $10.09B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.